. 2015 May 5;59:10.3402/fnr.v59.25974. doi: 10.3402/fnr.v59.25974

Table 1.

Effect of medication use and chronic diseases on serum Mg concentration

Characteristic	Participants (n)³				ANOVA p-value⁴

	SW	WW	SM	WM	Characteristic	Race	Gender	Characteristic×race	Characteristic×gender
DM					<0.0001	NS	<0.0001	NS	0.0002
No	113^b	208^a	126^b	98^ab
Yes	11	4	14	3
OM¹					NS	0.0002	<0.0001	NS	NS
No	103	173	102	81
Yes	21	39	38	20
CD²					NS	0.01	0.001	NS	NS
No	115	201	128	91
Yes	9	11	12	10

Taking one or more of the following medications: amlodipine/atorvastatin, atorvastatin, calcium channel blockers, cholestyramine, cimetidine, colesevelam, colestipol, corticosteroids, estrogens, ezetimibe/simvastatin, fenofibrate, fluvastatin, gemfibrozil, heparin, isoniazid, ketoconazole, lovastatin, neomycin, niacin, niacin/lovastatin, orlistat, raloxifene, rifampin, rosuvastatin, simvastatin, thiazide diuretics, thioridazine, verapamil, or cholesterol-lowering medication.

Having one or more of the following diseases: celiac disease, chronic kidney disease, Crohn's disease, cystic fibrosis, heart disease, hyperthyroidism, liver dysfunction, primary hyperparathyroidism, tumor-induced osteomalacia, or Whipple's disease.

Values in a row without a common letter signify differences in the proportions of participants with that characteristic, p<0.05.

⁴

Data were analyzed using multifactorial ANOVA to test for effects and interactions of the independent variables (characteristic, race and gender) on serum Mg (dependent variable). NS, p≥0.05.

CD, chronic disease; DM, diabetes medication; NS, not significant; OM, other medication; SM, South Asian men; SW, South Asian women; WM, white men; WW, white women.